Chula Vista

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease4 trials
• Obesity2 trials
• Fatty liver disease (MASLD/MASH)1 trial
• High blood pressure1 trial
• Liver and biliary tract cancer1 trial
• Liver cirrhosis1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 33 trials
• Phase 22 trials
• Phase 11 trial
• Phase 1/21 trial

Status

• Completed3 trials
• Active, not recruiting2 trials
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• AstraZeneca7 trials

Running trials

• Recruiting

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

  NCT06749457· Phase 1/2· AstraZeneca· Source

• Active, not recruiting

  Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

  NCT05925803· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting

Closed trials

• Completed

  A Study in Participants With Non-cirrhotic NASH With Fibrosis

  NCT05638737· Phase 2· AstraZeneca· Source

• Completed

  A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

  NCT05432167· Phase 2· AstraZeneca· Source

• Terminated

  A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

  NCT05056727· Phase 3· AstraZeneca· Source

• Completed

  A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

  NCT04483947· Phase 1· AstraZeneca· Source